Heartflow, Inc. $HTFL Position Cut by Lisanti Capital Growth LLC

Lisanti Capital Growth LLC lowered its holdings in shares of Heartflow, Inc. (NASDAQ:HTFL) by 18.1% during the third quarter, HoldingsChannel reports. The firm owned 155,295 shares of the company’s stock after selling 34,380 shares during the quarter. Heartflow comprises 2.1% of Lisanti Capital Growth LLC’s holdings, making the stock its 6th largest holding. Lisanti Capital Growth LLC’s holdings in Heartflow were worth $7,726,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of the company. GAMMA Investing LLC boosted its holdings in shares of Heartflow by 75.1% in the 3rd quarter. GAMMA Investing LLC now owns 641 shares of the company’s stock valued at $32,000 after buying an additional 275 shares during the last quarter. IFP Advisors Inc grew its position in shares of Heartflow by 844.7% in the third quarter. IFP Advisors Inc now owns 803 shares of the company’s stock valued at $40,000 after purchasing an additional 718 shares during the last quarter. Integrated Wealth Concepts LLC acquired a new stake in shares of Heartflow during the second quarter worth $53,000. Essential Partners LLC bought a new stake in Heartflow in the 1st quarter valued at about $57,000. Finally, Sterling Capital Management LLC grew its holdings in shares of Heartflow by 797.9% during the 3rd quarter. Sterling Capital Management LLC now owns 2,532 shares of the company’s stock worth $126,000 after purchasing an additional 2,250 shares in the last quarter.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on HTFL shares. Wall Street Zen downgraded shares of Heartflow from a “buy” rating to a “hold” rating in a research note on Saturday, November 7th. Stifel Nicolaus lifted their target price on Heartflow from $40.00 to $45.00 and gave the stock a “buy” rating in a report on Friday, August 14th. JPMorgan Chase & Co. increased their price objective on shares of Heartflow from $35.00 to $45.00 and gave the stock an “overweight” rating in a research report on Friday, August 14th. Canaccord Genuity Group lifted their price target on shares of Heartflow from $45.00 to $56.00 and gave the company a “buy” rating in a research report on Tuesday, September 22nd. Finally, Morgan Stanley increased their price objective on Heartflow from $35.00 to $40.00 and gave the stock an “equal weight” rating in a research note on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $48.62.

Insider Buying and Selling at Heartflow

In other news, CFO Vikram Verghese sold 3,587 shares of the firm’s stock in a transaction on Monday, November 9th. The stock was sold at an average price of $53.15, for a total value of $190,649.05. Following the completion of the transaction, the chief financial officer directly owned 149,587 shares of the company’s stock, valued at $7,950,549.05. This trade represents a 2.34% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO John Farquhar sold 38,900 shares of Heartflow stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $55.74, for a total value of $2,168,286.00. Following the transaction, the chief executive officer directly owned 251,983 shares of the company’s stock, valued at $14,045,532.42. The trade was a 13.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 347,963 shares of company stock valued at $17,210,559 over the last three months. 7.70% of the stock is currently owned by insiders.

Heartflow Trading Up 5.9%

HTFL opened at $59.10 on Thursday. Heartflow, Inc. has a twelve month low of $20.13 and a twelve month high of $60.66. The company’s 50-day moving average price is $51.73 and its two-hundred day moving average price is $35.00.

Heartflow (NASDAQ:HTFL) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.22) by $0.15. The company had revenue of $64.08 million during the quarter. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The business’s quarterly revenue was up 47.7% on a year-over-year basis. Sell-side analysts expect that Heartflow, Inc. will post -0.75 EPS for the current fiscal year.

Heartflow Company Profile

HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.